Thank you for contacting us.
A member of our team will reply within 24 hours of your submission, during regular business hours. Our regular busines hours are 9:00am-8:00pm EST; Monday to Friday.
Topical Polls and Industry Trends
Leaders in Oncology
In oncology, the pace is fast and the competition fierce. Leaders stand out not only for groundbreaking therapies but also for building trust, brand recognition, and robust patient support programs.
MD Analytics surveyed U.S. and Canadian oncologists to learn which companies are in the lead and why. The findings reveal that perceived leadership goes beyond science alone; it’s about a commitment to patient care that resonates with both clinicians and patients.
View our latest infographic and blog to see how top companies are positioning themselves to maintain momentum and secure their place at the front of the field.
Use of Real-World Evidence in Oncology
Real-world evidence (RWE) is no longer a secondary data source, it’s becoming a core input in oncology treatment decisions. In a new survey of Canadian and U.S. oncologists, MD Analytics explores how RWE is being used in clinical practice, the scenarios where it’s most valuable, and what challenges still exist in applying it effectively.
Our latest infographic reveals where oncologists see the greatest benefit from RWE, how it supports complex decision-making, and what pharmaceutical companies can do to improve access, data quality, and clinical relevance.
The Shifting Demographics of Oncology Patients
A recent survey of oncologists in North America reveals a rising trend: more patients are being diagnosed with solid tumor cancers at a younger age. Backed by recent epidemiological studies, this shift is particularly evident in breast and colorectal cancers.
This demographic change is expected to impact treatment strategies, patient management, and how pharmaceutical companies support and communicate with younger patients. Explore the infographic to learn more about the implications for oncology care.